Search

West Pharmaceutical Services Inc

Suletud

SektorTervishoid

339.57 -0.8

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

338

Max

342.48

Põhinäitajad

By Trading Economics

Sissetulek

15M

154M

Müük

27M

872M

P/E

Sektori keskmine

43.732

56.659

Aktsiakasum

2.37

Dividenditootlus

0.26

Kasumimarginaal

17.654

Töötajad

10,800

EBITDA

-39M

179M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+18.86% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.26%

2.18%

Järgmine tulemuste avaldamine

22. okt 2026

Järgmine dividendimakse kuupäev

18. nov 2026

Järgmine aktsia dividendi kuupäev (ex-date)

11. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-885M

24B

Eelmine avamishind

340.37

Eelmine sulgemishind

339.57

Uudiste sentiment

By Acuity

100%

0%

329 / 339 Pingereas Healthcare

West Pharmaceutical Services Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. sept 2026, 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

3. sept 2026, 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

1. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

31. aug 2026, 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

28. aug 2026, 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

27. aug 2026, 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

26. aug 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

25. aug 2026, 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

24. aug 2026, 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

21. aug 2026, 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

20. aug 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

19. aug 2026, 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

18. aug 2026, 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

17. aug 2026, 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

14. aug 2026, 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

13. aug 2026, 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

12. aug 2026, 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

11. aug 2026, 19:26 UTC

West Pharmaceutical Services Inc is trading higher today, reflecting a gain since Monday. Market participants are watching upcoming U.S. inflation reports closely.

10. aug 2026, 23:46 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a level near the upper end of their one-month range. No specific news was identified.

7. aug 2026, 19:46 UTC

West Pharmaceutical Services Inc is trading higher during Friday's session, reflecting market strength. Shares remain above their 20-day moving average despite an earlier pullback.

6. aug 2026, 20:51 UTC

West Pharmaceutical Services Inc. is roughly flat in after-market hours amid broader market declines and ahead of the upcoming non-farm payrolls report.

5. aug 2026, 19:56 UTC

West Pharmaceutical Services shares are trading higher amid broader market gains, influenced by recent declines in oil prices and potential supply resolution.

4. aug 2026, 20:51 UTC

West Pharmaceutical Services shares declined in after-hours trading, shifting downward despite an initial gain. No specific company news was identified for the movement.

3. aug 2026, 19:46 UTC

News

Citigroup raised its price target on West Pharmaceutical Services to $412, maintaining a Buy rating following strong quarterly results and increased revenue guidance.

31. juuli 2026, 23:01 UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

29. juuli 2026, 19:44 UTC

Macro Event

West Pharmaceutical Services is slightly lower amid broader market declines following the Federal Reserve's decision to keep interest rates steady.

28. juuli 2026, 23:31 UTC

West Pharmaceutical Services shares declined in after-market trading, tracking broader market losses amid rising competition in the semiconductor sector.

27. juuli 2026, 19:41 UTC

News

Evercore ISI raised its price target on West Pharmaceutical Services to $425, contributing to positive sentiment as shares trade higher since Friday's close.

24. juuli 2026, 22:01 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours, continuing a trend of recent declines despite earlier volatility during the session.

Võrdlus sarnastega

Hinnamuutus

West Pharmaceutical Services Inc Prognoos

Hinnasiht

By TipRanks

18.86% tõus

12 kuu keskmine prognoos

Keskmine 407.38 USD  18.86%

Kõrge 447 USD

Madal 365 USD

Põhineb 9 Wall Streeti analüütiku instrumendi West Pharmaceutical Services Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

9 ratings

8

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

329 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat